Skip to main content
. 2020 Nov 25;14(1):13. doi: 10.3892/mco.2020.2175

Figure 2.

Figure 2

(A and B) PFS (C and D) OS of patients with soft tissue sarcoma treated with eribulin by treatment line. PFS, progression-free survival; OS, overall survival; CI, confidence interval.